Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
115.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.50 (1.299%)
Market Cap: £255.31m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Further Buyback Programme

31 Mar 2025 15:30

RNS Number : 9769C
Real Estate Credit Investments Ltd
31 March 2025
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

This announcement contains inside information as defined under the Market Abuse Regulation. (EU) No. 596/2014 as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. This announcement has been prepared by, and is the sole responsibility of, Real Estate Credit Investments Limited. This announcement has been released by Lucy McDowall of Aztec Financial Services (Guernsey) Limited, Secretary of the Company.

 31 March 2025

Real Estate Credit Investments Limited

("RECI" or the "Company")

Further Buyback Programme

The Board of Directors of the Company announces that, having reviewed the current circumstances and assessed the Company's level and allocation of cash available for deployment, it intends to undertake a further buyback programme (the "Programme") which will run to 30 September 2025. The aggregate purchase price of all shares acquired under the Programme will be no greater than £10.0 million. The Company's buyback programme announced on 27 September 2024 will expire on 31 March 2025.

 

The Company's initial buyback programme was announced on 31 August 2023, with an aggregate purchase price of all shares purchased of no more than £5.0 million. Pursuant to that programme, a total of 4,095,000 ordinary shares of no par value each ("Ordinary Shares") were purchased for treasury for an aggregate amount of £5.0 million. The Company announced a successor buyback programme on 28 March 2024, with an aggregate purchase price of all shares purchased of no more than £10.0 million, pursuant to which a total of 3,343,474 Ordinary Shares were purchased for treasury for an aggregate amount of £4,148,809. A further buyback programme was then announced on 27 September 2024 for £10.0 million, which has not been utilised.

 

As previously announced, the Company considers all options when deciding on the appropriate allocation of the Company's available cash resources, including implementing share buybacks and investment in attractive high yielding opportunities to enhance RECI's returns. Since the commencement of the previous buyback programme, the Company's Ordinary Shares have traded at an average discount to net asset value of 13.9%, which is in line with the average share price discount since the Company last bought back shares of 13.7%.

 

The Company's principal focus has been on new and existing investment opportunities that can deliver an attractive yield to shareholders, particularly in the context of an improved discount position since the commencement of the buyback programme, and the authority to make share buybacks has not been utilised during the last buyback programme. Nevertheless, the Company remains committed to considering the ongoing deployment of available cash resources to share buybacks and has accordingly introduced a successor programme of up to £10.0 million for a further six months.

 

The Programme will occur within the limitations of RECI's existing general authority to purchase no more than 33,491,382 Ordinary Shares as granted by shareholders at the Company's annual general meeting held on 18 September 2024, which is expected to be extended at the Company's annual general meeting in 2025.

The Company has appointed Panmure Liberum to make market purchases of Ordinary Shares in respect of the Programme. Panmure Liberum will purchase the Ordinary Shares as principal (and not as agent) and sell them on to the Company. The Company intends that any Ordinary Shares purchased by the Company will be held in treasury.

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Panmure Liberum's engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's 2024 annual general meeting; and the EU Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended); and Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

The maximum price payable per share (exclusive of expenses) must not exceed the higher of: (i) 105% of the average middle market quotations for the five business days preceding the date of purchase; and (ii) the higher of the last independent trade and the highest current independent bid on the London Stock Exchange.

A buy-back of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the Exchange (and could exceed the 25% limit of the average daily trading volume of the preceding 20 business days as referred to in the Commission Delegated Regulation (EU) No. 2016/1052 on buy-back programmes (as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018)).

Any purchase of Ordinary Shares by the Company will be notified through an RIS announcement by no later than 7.30 a.m. on the following business day. Shareholders should note that whether a buyback of Ordinary Shares is made is based on a number of factors and, accordingly, no expectation or reliance should be placed on Panmure Liberum exercising such discretion on any one or more occasions. There is no guarantee that the Programme will be implemented in full or that any Ordinary Shares will be repurchased by the Company.

 

Enquiries:

Cheyne Capital Management (UK) LLP (Investment Manager)

+44 (0) 20 7968 7450

RECIIR@cheynecapital.com

 

 

 

Panmure Liberum (Corporate Broker)

+44 (0) 20 3100 2222

Darren Vickers/Alex Collins

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDUFLFEISESD
Date   Source Headline
29th Aug 20177:00 amRNSNotice of Suspension of Preference Shares
16th Aug 20177:00 amRNSNotice of Redemption of Preference Shares
10th Aug 20177:00 amRNSDividend Declaration
4th Aug 20177:00 amRNSFact Sheet Announcement
31st Jul 20177:00 amRNSNotice of AGM
11th Jul 201711:21 amRNSNotification of Major Interest in Shares
11th Jul 20177:00 amRNSFact Sheet Announcement
10th Jul 20173:52 pmRNSNotification of Major Interest in Shares
5th Jul 20174:10 pmRNSNotification of Major Interest in Shares
5th Jul 20173:06 pmRNSNotification of Major Interest in Shares
4th Jul 20178:45 amRNSClose of Second Placing
28th Jun 20177:00 amRNSProposed Placing of New Ordinary Shares
16th Jun 20171:00 pmRNSPublication of Supplementary Prospectus
16th Jun 20177:00 amRNSDividend Declaration - Ordinary Dividend
16th Jun 20177:00 amRNSAnnual Financial Report
6th Jun 20177:00 amRNSFact Sheet Announcement
23rd May 20177:00 amRNSDividend Declaration - Preference Dividend
19th May 201711:33 amRNSNotification of Major Interest in Shares
18th May 20171:41 pmRNSNotification of Major Interest in Shares
12th May 20177:00 amRNSNotice of Results
5th May 20177:00 amRNSFact Sheet Announcement
4th May 20177:00 amRNSPortfolio Investment Announcement
13th Apr 20177:00 amRNSFact Sheet Announcement
29th Mar 20174:08 pmRNSDirector/PDMR Shareholding
28th Mar 20179:10 amRNSNotification of Major Interest in Shares
24th Mar 20174:34 pmRNSNotification of Major Interest in Shares
24th Mar 201710:00 amRNSDirector/PDMR Shareholding
24th Mar 201710:00 amRNSDirector/PDMR Shareholding
24th Mar 201710:00 amRNSDirector/PDMR Shareholding
22nd Mar 20171:11 pmRNSResult of EGM
8th Mar 20177:00 amRNSFact Sheet Announcement
2nd Mar 20171:13 pmRNSNotification of Major Interest in Shares
23rd Feb 20173:00 pmRNSClose of Initial Placing
23rd Feb 20171:00 pmRNSPublication of Prospectus and Initial Placing
9th Feb 201712:10 pmRNSProposed Placing Programme and Initial Placing
8th Feb 20173:00 pmRNSDividend Declaration - Preference Dividend
8th Feb 20173:00 pmRNSDividend Declaration - Ordinary Dividend
7th Feb 20177:00 amRNSFact Sheet Announcement
6th Feb 201711:36 amRNSNotification of Major Interest in Shares
6th Jan 20177:00 amRNSFact Sheet Announcement
7th Dec 20167:00 amRNSFact Sheet Announcement
30th Nov 20167:00 amRNSDividend Declaration - Preference Dividend
30th Nov 20167:00 amRNSDividend Declaration - Ordinary Dividend
30th Nov 20167:00 amRNSCondensed Interim Financial Report
30th Nov 20167:00 amRNSHalf-year Report
3rd Nov 20167:00 amRNSFact Sheet Announcement
25th Oct 201611:30 amRNSChange of Name
5th Oct 20167:00 amRNSFact Sheet Announcement
16th Sep 20162:00 pmRNSResult of AGM
7th Sep 20167:00 amRNSFact Sheet Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.